Home Alzheimer’s Disease Simple Modifications of Phase I Trial Designs Could Reduce Time Required for...

Simple Modifications of Phase I Trial Designs Could Reduce Time Required for New Advances

Phase I queue (IQ) designs were associated with reduced expected study durations compared to their parent designs without changing the risk limits or maximum tolerated dose selection operating characteristics, according to a recent study published in JAMA Network Open.

There were also minimal changes in the number of patients treated and the determination of the maximum tolerated dose in this study’s modified designs, without altering operating characteristics or exceeding the parent design’s risk limits.

“We observed in our phase I studies that these details can dramatically affect phase 1 study duration and such imperfections are present in every study,” wrote the researchers. “We can adapt designs to these imperfections to reduce the study duration while not exceeding the risk permitted in the parent design or affecting the operating characteristics.”

Overall, the…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

My Brain Tumor Taught Me To Shift My Perspective on These 5 Things

submitted by /u/andrewjoegeorge Continue Reading to the Source

Recent Comments